Posts Categorized: Canadian Agency for Drugs and Technologies in Health (CADTH)

CADTH PostMarket Drug Evaluation Request for Proposals

The new CADTH Post-Market Drug Evaluation (PMDE) Program will be launching a re-imagined evidence generation network in September 2022. The program will bring together an external network of Canada’s expert applied researchers, methodologists, and data analysts to provide evidence to answer questions posed by federal, provincial, and territorial decision-makers about post-market drug safety and effectiveness…. Read more »